CLINICAL_TRIALS
trial_result
· 2008-03-04
Clinical Trial Update: Valaciclovir to Prevent Transmission of Herpes Simplex Virus [Phase 3]
Summary
A Phase 3 trial evaluating valacyclovir to prevent transmission of herpes simplex virus has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Herpes Simplex | Phase 3 | Status: COMPLETED